| Secondary |
| Product Used For Unknown Indication |
35.9% |
| Malignant Melanoma |
12.4% |
| Colorectal Cancer |
11.3% |
| Prostate Cancer |
5.1% |
| Hypertension |
4.6% |
| Pain |
3.3% |
| Prophylaxis |
3.3% |
| Non-small Cell Lung Cancer |
2.8% |
| Hepatic Neoplasm Malignant |
2.6% |
| Nausea |
2.4% |
| Breast Cancer |
2.3% |
| Metastatic Renal Cell Carcinoma |
2.1% |
| Prostate Cancer Metastatic |
2.1% |
| Gastric Cancer |
1.8% |
| Diarrhoea |
1.6% |
| Premedication |
1.5% |
| Large Intestine Carcinoma |
1.3% |
| Lung Neoplasm Malignant |
1.3% |
| Non-hodgkin's Lymphoma |
1.3% |
| Constipation |
1.1% |
|
| Dyspnoea |
11.9% |
| White Blood Cell Count Decreased |
9.2% |
| Weight Decreased |
6.4% |
| Hypotension |
5.5% |
| Muscular Weakness |
5.5% |
| Nausea |
5.5% |
| Respiratory Failure |
5.5% |
| Thrombocytopenia |
5.5% |
| Urticaria |
5.5% |
| Vomiting |
5.5% |
| Neuropathy Peripheral |
4.6% |
| Neutropenia |
4.6% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
4.6% |
| Dyspnoea Exertional |
3.7% |
| Pulmonary Embolism |
3.7% |
| Death |
2.8% |
| Drug Interaction |
2.8% |
| Mycobacterium Tuberculosis Complex Test Positive |
2.8% |
| Speech Disorder |
2.8% |
| Adverse Reaction |
1.8% |
|
| Concomitant |
| Chemotherapy |
13.6% |
| Product Used For Unknown Indication |
13.5% |
| Metastases To Bone |
12.0% |
| Breast Cancer |
9.8% |
| Multiple Myeloma |
6.2% |
| Acute Lymphocytic Leukaemia |
5.3% |
| Neoplasm Malignant |
4.7% |
| Pain |
4.6% |
| Neutropenia |
4.5% |
| Prostate Cancer |
3.5% |
| Breast Cancer Metastatic |
3.3% |
| Prostate Cancer Metastatic |
3.3% |
| Acute Myeloid Leukaemia |
2.5% |
| Depression |
2.5% |
| Prophylaxis |
2.1% |
| Lung Neoplasm Malignant |
1.9% |
| Idiopathic Thrombocytopenic Purpura |
1.9% |
| Diabetes Mellitus |
1.7% |
| Hypertension |
1.5% |
| Antibiotic Prophylaxis |
1.4% |
|
| Tooth Extraction |
12.2% |
| Death |
6.7% |
| Weight Increased |
6.7% |
| Neutropenia |
6.4% |
| Wound Dehiscence |
6.4% |
| Drug Ineffective |
5.8% |
| Wound Drainage |
5.5% |
| Weight Decreased |
5.2% |
| Tooth Loss |
4.9% |
| Tumour Invasion |
4.6% |
| Vomiting |
4.6% |
| Pyrexia |
4.3% |
| X-ray Abnormal |
4.0% |
| White Blood Cell Count Decreased |
3.6% |
| Bone Pain |
3.3% |
| Nausea |
3.3% |
| Renal Failure |
3.3% |
| Thrombocytopenia |
3.3% |
| Febrile Neutropenia |
3.0% |
| Infection |
3.0% |
|
| Interacting |
| Breast Cancer Metastatic |
50.0% |
| Tuberculosis |
50.0% |
|
|
